Geoffrey Shapiro, Site 002

Dana-Farber Cancer InstBoston, Massachusetts - 02115 (617-632-5053) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS6
- SINCE2009

Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
March 2009 - December 2011
Neoplasms
Paclitaxel
Docetaxel
Capecitabine
Doxorubicin
Ixabepilone
Brivanib Alaninate



